The Influence of Heart Failure Self-care on Health Outcomes: Hypothetical Cardioprotective Mechanisms
暂无分享,去创建一个
[1] David C. Sheridan,et al. Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment , 2005, Circulation.
[2] R. Califf,et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). , 1999, American heart journal.
[3] A. Katz. Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses , 2003, Journal of cellular and molecular medicine.
[4] S. Yusuf,et al. Acute precipitants of congestive heart failure exacerbations. , 2001, Archives of internal medicine.
[5] G. Schuler,et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.
[6] B. Riegel,et al. Development and testing of a clinical tool measuring self-management of heart failure. , 2000, Heart & lung : the journal of critical care.
[7] R. Schrier,et al. Pathophysiology of volume overload in acute heart failure syndromes. , 2006, The American journal of medicine.
[8] Karl Swedberg,et al. Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey. , 2007, The American journal of cardiology.
[9] I. Borini,et al. State of the art of cardiac surgery in patients with congenital heart disease , 2007, Journal of cardiovascular medicine.
[10] D. Giurgiutiu,et al. Utilization efficacy of noninvasive and invasive cardiac testing among stable cardiac patients undergoing noncardiac surgery. , 2006, Cardiovascular revascularization medicine : including molecular interventions.
[11] B. Riegel,et al. Predictors of self-care in persons with heart failure. , 1999, Heart & lung : the journal of critical care.
[12] V. Hasselblad,et al. Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial , 2007, European journal of heart failure.
[13] J. Granton,et al. Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology , 2003, Critical care.
[14] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[15] A. Kurtz,et al. Blood Pressure–Dependent Inhibition of Renin Secretion Requires A1 Adenosine Receptors , 2005, Hypertension.
[16] D. Webb,et al. Endothelin as a regulator of cardiovascular function in health and disease , 1998, Journal of hypertension.
[17] K. Dracup,et al. Treatment-seeking delays in heart failure patients. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[18] A. Michalsen,et al. Preventable causative factors leading to hospital admission with decompensated heart failure , 1998, Heart.
[19] D. Newby,et al. Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme Inhibition , 2004, Hypertension.
[20] G. Huster,et al. Characterization of the precipitants of hospitalization for heart failure decompensation. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[21] D. Gaze. The role of existing and novel cardiac biomarkers for cardioprotection. , 2007, Current opinion in investigational drugs.
[22] P. Macfarlane,et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial , 2003, The Lancet.
[23] S. O'Rourke. Antianginal actions of beta-adrenoceptor antagonists. , 2007, American journal of pharmaceutical education.
[24] Douglas L Mann,et al. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.
[25] Allison R Webel,et al. Daily Variability in Dyspnea, Edema and Body Weight in Heart Failure Patients , 2007, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[26] M. Packer. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.
[27] Mario Petretta,et al. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy. , 2005, Journal of cardiac failure.
[28] B. Bozkurt,et al. Basic mechanisms in heart failure: the cytokine hypothesis. , 1996, Journal of cardiac failure.
[29] C. Hengstenberg,et al. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. , 2005, International journal of cardiology.
[30] S. Anker,et al. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.
[31] P. Tricoci,et al. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. , 2004, Journal of clinical periodontology.
[32] Corrine Y Jurgens,et al. Somatic awareness, uncertainty, and delay in care-seeking in acute heart failure. , 2006, Research in nursing & health.
[33] M. Sebern,et al. Psychometric testing of the self-care of heart failure index. , 2004, Journal of cardiac failure.
[34] T. Kanda,et al. Interleukin-6 and cardiovascular diseases. , 2004, Japanese heart journal.
[35] G. Fonarow. Acute decompensated heart failure: challenges and opportunities. , 2007, Reviews in cardiovascular medicine.
[36] S. Anker,et al. Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications. , 2004, Basic research in cardiology.
[37] W. Abraham,et al. Hormones and hemodynamics in heart failure. , 1999, The New England journal of medicine.
[38] B. Riegel,et al. A Situation-Specific Theory of Heart Failure Self-care , 2008, The Journal of cardiovascular nursing.
[39] D. Webb,et al. Endothelin antagonism in pulmonary hypertension, heart failure, and beyond , 2005, Heart.
[40] P. Aukrust,et al. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. , 2005, The American journal of cardiology.
[41] David D. Shin,et al. Congestion is an important diagnostic and therapeutic target in heart failure. , 2006, Reviews in cardiovascular medicine.
[42] H. Abu‐Saad,et al. Self-care behaviour of patients with heart failure. , 2000, Scandinavian journal of caring sciences.
[43] G. Schuler,et al. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure , 2003, European journal of heart failure.
[44] G. Garin,et al. Vascular shear stress and activation of inflammatory genes , 2006, Current atherosclerosis reports.
[45] G. Fonarow,et al. Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.
[46] N. Tkacs,et al. Current Concepts of Neurohormonal Activation in Heart Failure: Mediators and Mechanisms , 2008, AACN advanced critical care.
[47] John Mullooly,et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. , 2003, The New England journal of medicine.
[48] C. Ferrario,et al. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. , 2006, The American journal of cardiology.
[49] P. Poole‐Wilson,et al. Should beta‐blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET , 2007, European journal of heart failure.
[50] T. Ueland,et al. Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications , 2005, Annals of medicine.
[51] N. Khaper,et al. Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.
[52] M. Domanski,et al. Diuretic use, progressive heart failure, and death in patients in the DIG study. , 2006, Journal of cardiac failure.
[53] Salim Yusuf,et al. Effects of exercise training in patients with heart failure: the Exercise Rehabilitation Trial (EXERT). , 2002, American heart journal.
[54] J. Ulrich. [Physiology of the heart]. , 1950, Zeitschrift fur Kreislaufforschung.
[55] S. Yusuf,et al. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure , 2006, Epidemiology and Infection.
[56] M. Gheorghiade,et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.
[57] W. Mosterd,et al. Safety and effects of physical training in chronic heart failure. Results of the Chronic Heart Failure and Graded Exercise study (CHANGE) , 1999, European heart journal.
[58] H. Ruskoaho. Cardiac hormones as diagnostic tools in heart failure. , 2003, Endocrine reviews.
[59] T. Lennie. Nutrition Self-care in Heart Failure: State of the Science , 2008, The Journal of cardiovascular nursing.
[60] D. Dávila,et al. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. , 2005, International journal of cardiology.
[61] P. Hauptman. Medication adherence in heart failure , 2008, Heart Failure Reviews.
[62] K. Dickstein,et al. [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[63] J. Heywood,et al. Optimal use of diuretics in patients with heart failure , 2007, Current treatment options in cardiovascular medicine.
[64] P. Persson. Renin: origin, secretion and synthesis , 2003, Journal of Physiology.
[65] J. Nessler,et al. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol. , 2008, Kardiologia polska.
[66] S. Anker,et al. Tumour necrosis factor-α and the failing heart , 2003, Basic Research in Cardiology.
[67] A. Ferreira,et al. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure , 2004, European journal of heart failure.
[68] M. Gheorghiade,et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.
[69] G. Lip,et al. Hibernating myocardium in heart failure , 2005, Expert review of cardiovascular therapy.
[70] Irina Cleemput,et al. Economic implications of non-compliance in health care , 2002, The Lancet.
[71] J. N. Sharma. The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection , 2006, InflammoPharmacology.
[72] A. Farré,et al. Heart Failure, Redox Alterations, and Endothelial Dysfunction , 2001, Hypertension.
[73] Christopher M O'Connor,et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.
[74] P. F. F. G. R. Heyndrickx M.D.. Hibernating myocardium , 2004, Basic Research in Cardiology.
[75] B. Riegel,et al. Psychometric Testing of the Heart Failure Somatic Awareness Scale , 2006, The Journal of cardiovascular nursing.
[76] S. Vatner,et al. Hibernating myocardium. , 1998, The New England journal of medicine.